GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Mead Johnson Nutrition Co (NYSE:MJN) » Definitions » EBITDA per Share

Mead Johnson Nutrition Co (Mead Johnson Nutrition Co) EBITDA per Share : $5.07 (TTM As of Mar. 2017)


View and export this data going back to 2009. Start your Free Trial

What is Mead Johnson Nutrition Co EBITDA per Share?

Mead Johnson Nutrition Co's EBITDA per Share for the three months ended in Mar. 2017 was $1.00. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2017 was $5.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Mead Johnson Nutrition Co's EBITDA per Share or its related term are showing as below:

MJN's 3-Year EBITDA Growth Rate is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 6.8
* Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.

Mead Johnson Nutrition Co's EBITDA for the three months ended in Mar. 2017 was $185 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.


Mead Johnson Nutrition Co EBITDA per Share Historical Data

The historical data trend for Mead Johnson Nutrition Co's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mead Johnson Nutrition Co EBITDA per Share Chart

Mead Johnson Nutrition Co Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.49 5.25 5.38 5.24 5.01

Mead Johnson Nutrition Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 1.29 1.39 1.38 1.00

Mead Johnson Nutrition Co EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Mead Johnson Nutrition Co's EBITDA per Share for the fiscal year that ended in Dec. 2016 is calculated as

EBITDA per Share(A: Dec. 2016 )
=EBITDA/Shares Outstanding (Diluted Average)
=931.6/185.800
=5.01

Mead Johnson Nutrition Co's EBITDA per Share for the quarter that ended in Mar. 2017 is calculated as

EBITDA per Share(Q: Mar. 2017 )
=EBITDA/Shares Outstanding (Diluted Average)
=184.6/183.900
=1.00

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mead Johnson Nutrition Co  (NYSE:MJN) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Mead Johnson Nutrition Co EBITDA per Share Related Terms

Thank you for viewing the detailed overview of Mead Johnson Nutrition Co's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mead Johnson Nutrition Co (Mead Johnson Nutrition Co) Business Description

Traded in Other Exchanges
N/A
Address
Mead Johnson Nutrition makes, distributes, and markets pediatric nutrition products worldwide under a variety of brands, including Enfamil, its largest label, along with Sustagen, Enfagrow, and Nutramigen. Infant formula represented 59% of 2015 sales and children's nutrition 39%, with expectant and nursing mother nutrition and pediatric vitamins comprising the remainder. The company sells its products globally; 73% of sales were generated outside the United States in 2015. At about 30% of revenue, China is the company's largest market.
Executives
Kimberly A Casiano director C/O FORD MOTOR COMPANY, ONE AMERICAN ROAD, DEARBORN MI 48126
James E. Shiah officer: SVP and Controller 2 PARK AVENUE, NEW YORK NY 10016
Howard B Bernick director 1100 N WOOD DALE RD, WOOD DALE IL 60191
Michael A. Sherman director 3000 KENT AVE STE A1-100, WEST LAFAYETTE IN 47906
Robert S Singer director 6301 FITCH PATH, NEW ALBANY OH 43054
Celeste A. Clark director C/O ADVANCEPIERRE FOODS HOLDINGS, INC., 9987 CARVER ROAD, BLUE ASH OH 45242
Peter Gervis Ratcliffe director
Steven Altschuler director MEAD JOHNSON NUTRITION COMPANY, 2701 PATRIOT BLVD, GLENVIEW IL 60026
Patrick M Sheller officer: SVP, Gen. Counsel & Secretary 343 STATE STREET, ROCHESTER NY 14650
Elliot Sigal director
James M Cornelius director
Michael Grobstein director C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Anna C Catalano director 1313 NORTH MARKET STREET, WILMINGTON DE 19894
Peter G Leemputte officer: EVP and CFO CHICAGO TITLE CORP, 171 N CLARK ST, CHICAGO IL 80601
Lynn H Clark officer: Sr. VP, Human Resources 2400 WEST LLOYD EXPRESSWAY, EVANSVILLE IL 47721

Mead Johnson Nutrition Co (Mead Johnson Nutrition Co) Headlines

From GuruFocus

David Rolfe Comments on Mead Johnson

By Holly LaFon Holly LaFon 04-14-2017

David Rolfe Comments on Mead Johnson

By Holly LaFon 10-15-2015

Mead Johnson Is Not Delivering

By Mark Yu Mark Yu 01-23-2017

Robert Karr Sells Stake in Mead Johnson Nutrition

By David Goodloe David Goodloe 02-15-2016

Officers and Directors Say "It's Time to Buy"

By Dr. Paul Price Dr. Paul Price 08-30-2015